
Pacific Biosciences of California, Inc.: shareholders and insiders
Price
$1.76
November 19, 2026Market cap $532M
What Ploutos Investor adds for Pacific Biosciences of California
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 28% since Nov 5, 2026, when the 10-Q these figures come from was filed ($2.43 then, $1.76 on Nov 19, 2026). The figures date from before that move.10-Q
Insiders and their shares
Purchases and sales by officers and directors from Nov 20, 2025 to Nov 19, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$3.4M
5 people
From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan60%
- The rest40%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $3.4M by 5 people
- 2025: no buys, no sales
- 2026: no buys, sold $3.4M by 5 people
- Nov 17, 2026William MeyerChief Accounting OfficerKind
- Nov 17, 2026Kathy OrdonezDirectorKind
- Oct 6, 2026James R Gibson IIChief Financial OfficerKind10b5-1
- Oct 6, 2026James R Gibson IIChief Financial OfficerKind10b5-1
- Aug 17, 2026Oene Mark VanPresident & CEOKind
- Aug 10, 2026Oene Mark VanPresident & CEOKind
- Apr 1, 2026James R Gibson IIKind
- Mar 3, 2026Michele FarmerKind
- Mar 3, 2026Oene Mark VanKind
- Mar 3, 2026Christian O HenryKind
- Feb 18, 2026Michele FarmerKind
- Feb 18, 2026Christian O HenryKind
- Feb 18, 2026Oene Mark VanKind
- Feb 17, 2026Michele FarmerKind
- Feb 17, 2026Christian O HenryKind
- Feb 17, 2026Oene Mark VanKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | William MeyerChief Accounting Officer | 54.9K | – | – | Form 4 | |
| Nov 17, 2026 | Kathy OrdonezDirector | 18.6K | $1.78 | $33.1K | Form 4 | |
| Oct 6, 2026 | James R Gibson IIChief Financial Officer | 10b5-1 | 500.0K | $1.18 | $590.0K | Form 4 |
| Oct 6, 2026 | James R Gibson IIChief Financial Officer | 10b5-1 | 661.8K | $3.11 | $2.1M | Form 4 |
| Aug 17, 2026 | Oene Mark VanPresident & CEO | 26.9K | $1.13 | $30.4K | Form 4 | |
| Aug 10, 2026 | Oene Mark VanPresident & CEO | 489.1K | – | – | Form 4 | |
| Apr 1, 2026 | James R Gibson II | 88.2K | $1.37 | $120.8K | Form 4 | |
| Mar 3, 2026 | Michele Farmer | 2,979 | $1.51 | $4.5K | Form 4 | |
| Mar 3, 2026 | Oene Mark Van | 6,504 | $1.51 | $9.8K | Form 4 | |
| Mar 3, 2026 | Christian O Henry | 12.5K | $1.51 | $18.9K | Form 4 | |
| Feb 18, 2026 | Michele Farmer | 15.0K | $1.63 | $24.4K | Form 4 | |
| Feb 18, 2026 | Christian O Henry | 140.9K | $1.63 | $229.6K | Form 4 | |
| Feb 18, 2026 | Oene Mark Van | 55.1K | $1.63 | $89.8K | Form 4 | |
| Feb 17, 2026 | Michele Farmer | 35.2K | $1.58 | $55.6K | Form 4 | |
| Feb 17, 2026 | Christian O Henry | 331.8K | $1.58 | $524.2K | Form 4 | |
| Feb 17, 2026 | Oene Mark Van | 129.8K | $1.58 | $205.1K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 4, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by PACB's officers and directors from 2011 up to November 19, 2025, 15 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 10 more, back to 2011
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- T. Rowe Price Associates, Inc.Share of class10.8%
- ARK Investment Management LLCwith 1 more personShare of class9.59%
- BlackRock, Inc.Share of class7.70%
- The Goldman Sachs Groupwith 1 more personShare of class7.60%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 10.8% | 33.45M | Nov 6, 2026 | 13G | |
| ARK Investment Management LLCwith 1 more person | 9.59% | 29.78M | Aug 14, 20263 filings since Nov 4, 2025 | 13G/A | |
| BlackRock, Inc. | 7.70% | 22.87M | Apr 17, 2025 | 13G/A | |
| The Goldman Sachs Groupwith 1 more person | 7.60% | 23.52M | Nov 9, 2026 | 13G |
Fell to 5% or less (4)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter+17%
- Citadel Advisors (Griffin)In the quarter+129%
- Millennium Mgmt (Englander)In the quarter-5.3%
- D.E. ShawIn the quarter+66%
- Bridgewater (Dalio)In the quarter-32%
- Renaissance TechnologiesIn the quarter
- AQR CapitalIn the quarter-92%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | 5.59M | +17% | $13M | 0.02% |
| Citadel Advisors (Griffin) | 6.52M | +129% | $15M | 0.01% |
| Millennium Mgmt (Englander) | 3.75M | -5.3% | $8.9M | 0.01% |
| D.E. Shaw | 6.99M | +66% | $17M | 0.01% |
| Bridgewater (Dalio) | 69.7K | -32% | $200.0K | 0.00% |
| Renaissance Technologies | – | – | 0.00% | |
| AQR Capital | 106.6K | -92% | $300.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 15.5% of its shares outstanding were held short, -0.6% since the report before.
- Shares held short
- 46.93M
- 15.5%
- Since the report before47.22M on Sep 30, 2026
- -0.6%
- 2.2
- 21.42M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 26%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 35.12M
- Nov 15, 2023: Shares held short 39.23M
- Nov 30, 2023: Shares held short 33.43M
- Dec 15, 2023: Shares held short 34.89M
- Dec 29, 2023: Shares held short 37.78M
- Jan 12, 2024: Shares held short 36.00M
- Jan 31, 2024: Shares held short 34.19M
- Feb 15, 2024: Shares held short 40.38M
- Feb 29, 2024: Shares held short 43.54M
- Mar 15, 2024: Shares held short 45.57M
- Mar 28, 2024: Shares held short 49.05M
- Apr 15, 2024: Shares held short 48.52M
- Apr 30, 2024: Shares held short 52.82M
- May 15, 2024: Shares held short 56.58M
- May 31, 2024: Shares held short 54.25M
- Jun 14, 2024: Shares held short 54.57M
- Jun 28, 2024: Shares held short 56.47M
- Jul 15, 2024: Shares held short 61.68M
- Jul 31, 2024: Shares held short 57.10M
- Aug 15, 2024: Shares held short 59.96M
- Aug 30, 2024: Shares held short 61.03M
- Sep 13, 2024: Shares held short 46.53M
- Sep 30, 2024: Shares held short 51.64M
- Oct 15, 2024: Shares held short 48.54M
- Oct 31, 2024: Shares held short 50.41M
- Nov 15, 2024: Shares held short 52.14M
- Nov 29, 2024: Shares held short 54.38M
- Dec 13, 2024: Shares held short 53.06M
- Dec 31, 2024: Shares held short 56.85M
- Jan 15, 2025: Shares held short 60.54M
- Jan 31, 2025: Shares held short 60.40M
- Feb 14, 2025: Shares held short 66.69M
- Feb 28, 2025: Shares held short 61.98M
- Mar 14, 2025: Shares held short 53.41M
- Mar 31, 2025: Shares held short 54.60M
- Apr 15, 2025: Shares held short 47.20M
- Apr 30, 2025: Shares held short 49.21M
- May 15, 2025: Shares held short 56.95M
- May 30, 2025: Shares held short 52.02M
- Jun 13, 2025: Shares held short 39.64M
- Jun 30, 2025: Shares held short 47.37M
- Jul 15, 2025: Shares held short 44.38M
- Jul 31, 2025: Shares held short 41.87M
- Aug 15, 2025: Shares held short 42.17M
- Aug 29, 2025: Shares held short 37.11M
- Sep 15, 2025: Shares held short 45.55M
- Sep 30, 2025: Shares held short 37.97M
- Oct 15, 2025: Shares held short 34.51M
- Oct 31, 2025: Shares held short 32.51M
- Nov 14, 2025: Shares held short 33.57M
- Nov 28, 2025: Shares held short 34.04M
- Dec 15, 2025: Shares held short 34.26M
- Dec 31, 2025: Shares held short 34.00M
- Jan 15, 2026: Shares held short 35.09M
- Jan 30, 2026: Shares held short 35.59M
- Feb 13, 2026: Shares held short 38.92M
- Feb 27, 2026: Shares held short 38.19M
- Mar 13, 2026: Shares held short 41.39M
- Mar 31, 2026: Shares held short 45.63M
- Apr 15, 2026: Shares held short 46.36M
- Apr 30, 2026: Shares held short 47.09M
- May 15, 2026: Shares held short 59.93M
- May 29, 2026: Shares held short 48.71M
- Jun 15, 2026: Shares held short 60.56M
- Jun 30, 2026: Shares held short 47.49M
- Jul 15, 2026: Shares held short 46.24M
- Jul 31, 2026: Shares held short 49.00M
- Aug 14, 2026: Shares held short 53.41M
- Aug 31, 2026: Shares held short 49.58M
- Sep 15, 2026: Shares held short 48.89M
- Sep 30, 2026: Shares held short 47.22M
- Oct 15, 2026: Shares held short 46.93M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading62.3% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 62.3% of the shares in the reported trades were short sales, against 50.0% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 62.3%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 50.0%
- Change
- +12.3 pts
- Short sales a dayon average, of 6.39M shares
- 3.98M
- More than atof 3,666 US-listed companies, same days
- 88%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 16.7%
- Oct 14, 2026: Short sales 21.5%
- Oct 15, 2026: Short sales 25.9%
- Oct 16, 2026: Short sales 51.3%
- Oct 19, 2026: Short sales 44.5%
- Oct 20, 2026: Short sales 50.1%
- Oct 21, 2026: Short sales 66%
- Oct 22, 2026: Short sales 48.6%
- Oct 23, 2026: Short sales 47.2%
- Oct 26, 2026: Short sales 57.9%
- Oct 27, 2026: Short sales 65.2%
- Oct 28, 2026: Short sales 55.3%
- Oct 29, 2026: Short sales 64.8%
- Oct 30, 2026: Short sales 50%
- Nov 2, 2026: Short sales 52.3%
- Nov 3, 2026: Short sales 52.2%
- Nov 4, 2026: Short sales 71.2%
- Nov 5, 2026: Short sales 54.5%
- Nov 6, 2026: Short sales 51.5%
- Nov 9, 2026: Short sales 58.3%
- Nov 10, 2026: Short sales 63.5%
- Nov 11, 2026: Short sales 63.5%
- Nov 12, 2026: Short sales 61%
- Nov 13, 2026: Short sales 67.1%
- Nov 16, 2026: Short sales 71.3%
- Nov 17, 2026: Short sales 64%
- Nov 18, 2026: Short sales 65.3%
- Nov 19, 2026: Short sales 63.9%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Christian O HenrySee RemarksDirectly3.58M
- Oene Mark VanSee RemarksDirectly2.71M
- James R Gibson IISee RemarksDirectly1.08M
- Jeff EidelSee RemarksDirectly869.7K
- Susan G. KimSee RemarksDirectly695.7K
- Kathy OrdonezDirectorDirectly384.4K
- Michele FarmerSee RemarksDirectly305.9K
- William MeyerChief Accounting OfficerDirectly98.9K
- David W MelineDirectorDirectly40.0K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Christian O HenrySee Remarks | 3.58M | – | Mar 3, 2026 | Form 4 |
| Oene Mark VanSee Remarks | 2.71M | – | Aug 17, 2026 | Form 4 |
| James R Gibson IISee Remarks | 1.08M | – | Oct 6, 2026 | Form 4 |
| Jeff EidelSee Remarks | 869.7K | – | Aug 19, 2024 | Form 4 |
| Susan G. KimSee Remarks | 695.7K | – | Sep 30, 2024 | Form 4 |
| Kathy OrdonezDirector | 384.4K | – | Nov 17, 2026 | Form 4 |
| Michele FarmerSee Remarks | 305.9K | – | Mar 3, 2026 | Form 4 |
| William MeyerChief Accounting Officer | 98.9K | – | Nov 17, 2026 | Form 4 |
| David W MelineDirector | 40.0K | – | Mar 6, 2024 | Form 4 |
A lower bound: it counts only the 9 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- ARKGARK Genomic Revolution ETFWeight in the fund0.96%
- ARKKARK Innovation ETFWeight in the fund0.32%
- IBBiShares Biotechnology ETFWeight in the fund0.04%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.03%
- IWMiShares Russell 2000 ETFWeight in the fund0.01%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.01%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.01%
- VHTVanguard Health Care Index FundWeight in the fund0.00%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.00%
14 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 208
- Q4 2025: Managers 217
- Q1 2026: Managers 232
- Q2 2026: Managers 223
Institutional investors by quarter
The fund managers holding PACB, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 223 managers held 191M shares, worth $321M. During the quarter 24 opened a position, 33 closed one, 69 added and 76 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+28%
- ARK Investment ManagementIn the quarter-18%
- Softbank GroupIn the quarter
- Vanguard Capital ManagementIn the quarter+4.9%
- Geode Capital ManagementIn the quarter+9.0%
- Amova Asset Management AmericasIn the quarter-15%
- Sumitomo Mitsui Trust GroupIn the quarter-15%
- State StreetIn the quarter-2.6%
- Point72 (Cohen)In the quarter×16.8
- Two Sigma InvestmentsIn the quarter+21%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 32.34M | +28% | $54M |
| ARK Investment Management | 29.78M | -18% | $50M |
| Softbank Group | 20.45M | $34M | |
| Vanguard Capital Management | 13.40M | +4.9% | $23M |
| Geode Capital Management | 7.61M | +9.0% | $13M |
| Amova Asset Management Americas | 6.01M | -15% | $10M |
| Sumitomo Mitsui Trust Group | 6.01M | -15% | $10M |
| State Street | 5.96M | -2.6% | $10M |
| Point72 (Cohen) | 4.79M | ×16.8 | $8.0M |
| Two Sigma Investments | 4.24M | +21% | $7.1M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Pacific Biosciences of California's filings show?
Who buys and sells is one part of Pacific Biosciences of California's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have PACB's insiders bought or sold?
From Jun 4, 2026 to Nov 19, 2026 Pacific Biosciences of California's insiders bought 0 and sold $2.1M of shares on the market. 97% of the sales were under set 10b5-1 plans.
Which well-known managers hold PACB?
7 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $17M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.